Abstract
A unique experiment in bringing academic and industrial scientists together to tackle endemic infectious diseases has proved a success. The Tres Cantos Open Lab Foundation, guided and advised by independent experts, funds extended stays of academics at the campus of a pharmaceutical company, where they access the firm's resources in partnership with company scientists. Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has sustained the decade-long evolution of the model, whose distinctive features complement other public-private partnerships with similar goals.
Original language | English |
---|---|
Article number | e20211418 |
Number of pages | 3 |
Journal | Journal of Experimental Medicine |
Volume | 218 |
Issue number | 9 |
Early online date | 17 Aug 2021 |
DOIs | |
Publication status | Published - 6 Sept 2021 |